SMTL ID : 5qj2.4 (3 other biounits)

CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) OMPLEX WITH COMPOUND-20 AKA 7-((3-(1-METHYL-1H-PYRAZOL-3- YL)BENZYL)OXY)- 1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.82 Å

Oligo State

hetero-1-1-mer

Ligands

5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Non-functional Binders)

NAG.1: 6 residues within 4Å: Chain A: L.33 Chain B: R.327, F.328, G.330 Ligands: BMA.2, MAN.4 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:L.33 NAG.5: 6 residues within 4Å: Chain B: N.78, N.81, L.85, A.87, V.88, Q.90 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:A.87 Hydrogen bonds: B:N.78, B:N.81, B:V.88, B:Q.90 NAG.6: 5 residues within 4Å: Chain B: N.114, S.116, W.258, L.262 Ligands: NAG.7 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:N.114, B:S.116 NAG.7: 1 residues within 4Å: Ligands: NAG.6 No protein-ligand interaction detected (PLIP) NAG.8: 4 residues within 4Å: Chain B: N.206, S.208, V.209 Ligands: FUC.9 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:N.206

1 x BMA: beta-D-mannopyranose(Non-covalent)

BMA.2: 8 residues within 4Å: Chain B: Y.198, F.328, C.329, C.386, T.390 Ligands: NAG.1, MAN.3, MAN.4 No protein-ligand interaction detected (PLIP)

2 x MAN: alpha-D-mannopyranose(Non-covalent)

MAN.3: 2 residues within 4Å: Chain B: K.197 Ligands: BMA.2 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:K.197, B:K.197 MAN.4: 6 residues within 4Å: Chain A: W.32 Chain B: F.328, K.394 Ligands: NAG.1, BMA.2, FUC.9 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:K.394

1 x FUC: alpha-L-fucopyranose(Non-covalent)

FUC.9: 4 residues within 4Å: Chain B: V.209, R.393 Ligands: MAN.4, NAG.8 1 PLIP interactions: 1 interactions with chain B Hydrophobic interactions: B:V.209

1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.10: 24 residues within 4Å: Chain A: M.87, G.90, Q.91, D.94, D.98, F.99, T.100 Chain B: R.128, E.131, M.132, Y.185, T.218, F.221, R.222, Y.223, G.224, H.225, I.228, L.250, F.254, L.295, F.296, L.306, R.313 20 PLIP interactions: 17 interactions with chain B, 3 interactions with chain A, Hydrophobic interactions: B:F.221, B:F.221, B:R.222, B:Y.223, B:I.228, B:I.228, B:L.250, B:F.254, B:L.295, B:L.295, B:F.296, B:L.306, B:L.306, A:Q.91, A:Q.91 Salt bridges: B:R.128, B:R.222, B:R.313 Metal complexes: B:H.225 Hydrogen bonds: A:T.100

1 x CA: CALCIUM ION(Non-covalent)

CA.11: 6 residues within 4Å: Chain A: D.96 Chain B: T.57, S.58, F.59, D.61, S.63 5 PLIP interactions: 5 interactions with chain B Metal complexes: B:T.57, B:T.57, B:F.59, B:D.61, B:S.63

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wurtz, N.R. et al., Potent Triazolopyridine Myeloperoxidase Inhibitors. ACS Med Chem Lett (2018)

Release Date

2019-02-06

Peptides

Myeloperoxidase: A
Myeloperoxidase: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
I

Myeloperoxidase

Myeloperoxidase

Related Entries With Identical Sequence